BI 836826-GemOx

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 836826-GemOx, covering 2019-06-17 to 2019-06-17. Get the full timeline:

Most recent: Clinical Trial Update: To Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCL [Phase 2]

See pricing